Are large clinical trials in rapidly lethal diseases usually unethical?
- 1 February 2003
- journal article
- Published by Elsevier in The Lancet
- Vol. 361 (9358) , 695-697
- https://doi.org/10.1016/s0140-6736(03)12571-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The Continuing Unethical Conduct of Underpowered Clinical TrialsJAMA, 2002
- Depletion of intracellular Ca 2+ stores, phosphorylation of eIF2α, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazoleProceedings of the National Academy of Sciences, 1998
- Why “underpowered” trials are not necessarily unethicalThe Lancet, 1997
- PRAD1/Cyclin D1 Gene Overexpression in Mantle Cell LymphomaLeukemia & Lymphoma, 1996
- Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle- cell lymphomas and t(11q13)-associated leukemiasBlood, 1994
- Statistics and ethics in medical research: III How large a sample?BMJ, 1980